Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/7/05 → 8/12/08 |
Funding
- PPD Development (TMC125-C229)
- Tibotec Pharmaceuticals Ltd. (TMC125-C229)
Prot# TMC125-C229: An Open-Label Trial with TMC125 in HIV-1 Infected Subjects, Who Were Randomized to a TMC125 Treatment Arm in a Sponsor-Selected TMC125 Trial and Were Treated for at Least 48 Weeks
- Murphy, Robert Leo (PD/PI)
Project: Research project